The Small Nucleic Acid Based Drug Market is emerging as a transformative segment within the biopharmaceutical industry, driven by advances in molecular biology, genomics, and precision medicine. Small nucleic acid-based drugs—including small interfering RNA (siRNA), antisense oligonucleotides (ASOs), microRNA (miRNA), and aptamers—are designed to regulate gene expression and target...